Jérémie PARIENTE

PU-PH

Travaille sur

Abstracts rédigés ou co-rédigés

> Characterization of the perceptual-motor procedural learning deficit in adults with probable Developmental Coordination Disorder.
S. Seiwert, E. Martin, M. Planton, D. Méligne, J. Pariente, J. Tisseyre, J. Tallet
FENS Regional Meeting FRM 2023
Algarve Portugal
> Can neurodevelopmental disorders influence the course of neurodegenerative diseases?
Siguier Perrine, Jucla Mélanie, Pariente Jérémie
FENS Regional Meeting FRM 2023
Algarve Portugal
> Challenging the role of the thalamus in cognition : the neuropsychological impact of chronic thalamic stroke
Julie P. Vidal**, Lola Danet , Germain Arribarat , Jérémie Pariente , Patrice Péran , Emmanuel J. Barbeau
FENS 2022 (Federation of European Neurosciences Societies) –
> Neuroinflammation au stade prodromal de la maladie d’Alzheimer : une étude transversale en imagerie TEP de TSPO.
Dominique Gouilly, Maëva Fisher, Patrice Péran, Anne-Sophie Salabert, Elsa Bertrand, Marie Goubeaud, Johanne Germain, Béatrice Lemesle, Claire Thalamas, Camille Tisserand, Marie Rafiq, Marie Benaiteau, Jasmine Carlier, Pierre Payoux, Jérémie Pariente
Congrès francophone RFMASA Rencontre Francophone sur la Maladie d’Alzheimer et Syndromes Apparentés, 22-24 septembre 2021, Marseille.
> Faible cohérence de l’Aβ42 et du ratio Aβ42/40 dans le système de classification AT(N) Une étude rétrospective du CM2R de Neurologie au CHU de Toulouse
Dominique Gouilly, Camille Tisserand, Leonor Nogueira, Laura Saint-Lary , Vanessa Rousseau, Marie Benaiteau, Marie Rafiq, Jasmine Carlier, Emilie Milongo Rigal, Jean-Christophe Pagès, Jérémie Pariente
Congrès francophone RFMASA Rencontre Francophone sur la Maladie d’Alzheimer et Syndromes Apparentés, 22-24 septembre 2021, Marseille.
> Effect of Neflamapimod on neuroinflammation using DPA-714 in PET scan in selected Alzheimer disease patients.
Dominique Gouilly, Béatrice Lemesle, Pomies Elsa, Johanne Germain, Pierre Payoux, Mathieu Tafani, Anne-Sophie Brun-Salabert, Claire Thalamas, Marie Benaiteau, Jasmine Carlier, Fabienne Calvas, Patrice Péran, Jérémie Pariente
4th Nuclear Technologies for Health Symposium, 13-14 février 2020, Nantes
> Multimodal MRI-PET data-driven pipeline for the discrimination of prodromal Alzheimer’s Disease
Federico Nemmi, Pierre Payoux, Jérémie Pariente, Patrice Péran
9th ECCN, 2-3 mars 2020, Parisff
> Amyloid imaging in cerebral amyloid angiopathy –related intracerebral haemorrhage and Alzheimer’s disease: a voxel-wise approach.
Mélanie PLANTON, Laure Saint-Aubert, Nicolas Raposo, Pierre Payoux, Jean-Francois Albucher, Jean Marc Olivot, Patrice Péran, and Jérémie Pariente
5th Congress of the European Academy of Neurology, EAN 2019, 29 juin- 2 Juillet 2019 à Oslo, Norvège.
> Correlation between glucose metabolism and visual complaint in posterior cortical atrophy. A FGD-PET study.
Guerrier L., Cransac C., Pagès B., Saint-Aubert L., Péran P., Pariente J.
Réunion Francophone sur la Maladie d’Alzheimer & les Syndrome Apparentés (RFMASA). 11-14 Juin 2018, Lille, France.
> Cortex cingulaire et anosognosie dans la Maladie d’Alzheimer : étude en imagerie multimodale
Laura Guerrier, Johanne Le Men, Anaïs Gane, Mélanie Planton, Anne-Sophie Salabert, Pierre Payoux, Hervé Dumas, Fabrice Bonneville, Patrice Péran, Jérémie Pariente
41ièmes Journées de Printempsde SNLF - GRENOBLE Obtenu Prix de la meilleure communication orale
> Neuropsychological outcome after lobar and deep spontaneous intracerebral hemorrhage
Mélanie Planton (PhD), Laure Saint-Aubert (PhD), Nicolas Raposo (MD), Laura Branchu (MsC), Aicha Lyoubi (MD), Jean-François Albucher (MD), Jérémie Pariente (MD, PhD)
5th International Cerebral Amyloid Angiopathy - BOSTON
> Medial thalamic stroke and its impact on familiarity and recollection.
Lola Danet, Jérémie Pariente, Pierre Eustache, Nicolas Raposo, Igor Sibon, Jean-François Albucher, Fabrice Bonneville, Patrice Peran, Emmanuel J.Barbeau
1-BNS-SNLF, British and French Neuropsychological Societies - LONDRES 2-6th International Conference on Memory (ICOM-6) - BUDAPEST

Publications rédigées ou co-rédigées

> 58- Prevalence and characteristics of vascular cognitive impairment in a European cohort of adult patients with Moyamoya angiopathy.
Giroud M, Calviere L, Machado C, Reyes S, Mirabel H, Raposo N, Brandicourt P, Viguier A, Albucher JF, Bonneville F, Olivot JM, Péran P, Pariente J, Hervé D, Planton M.
J Neurol. 2024 Jul 17. doi: 10.1007/s00415-024-12555-2.
> 57- Exploring Memory Systems After Pediatric Posterior Fossa Tumor: From Memory Profile Comparisons in Nonirradiated Versus Irradiated Patients to Episodic Memory Tests Capable of Detecting Radiation-induced Hippocampal Damage.
Baudou E, Pollidoro L, Lemesle B, Maziero S, Tensaouti F, Bertozzi AI, Cazaux M, Costes M, Courbieres N, Dufour C, Grill J, Chaix Y, Pariente J, Laprie A.
Clin Oncol (R Coll Radiol). 2024 Jun 27:S0936-6555(24)00278-4. doi: 10.1016/j.clon.2024.06.054.
> 50- Can neurodevelopmental disorders influence the course of neurodegenerative diseases? A scoping review.
Siguier PLM, Planton M, Baudou E, Chaix Y, Delage A, Rafiq M, Wolfrum M, Gérard F, Jucla M, Pariente J.
Ageing Res Rev. 2024 Jun 8:102354. doi: 10.1016/j.arr.2024.102354.
> 49- Translocator protein (TSPO) genotype does not change cerebrospinal fluid levels of glial activation, axonal and synaptic damage markers in early Alzheimer’s disease.
Gouilly D, Vrillon A, Bertrand E, Goubeaud M, Catala H, Germain J, Ainaoui N, Rafiq M, Nogueira L, Mouton-Liger F, Planton M, Salabert AS, Hitzel A, Méligne D, Jasse L, Sarton B, Silva S, Lemesle B, Péran P, Payoux P, Thalamas C, Paquet C, Pariente J.
Neuroimage Clin. 2024 May 31;43:103626. doi: 10.1016/j.nicl.2024.103626.
> 39- Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screening.
Nicolas G, Zaréa A, Lacour M, Quenez O, Rousseau S, Richard AC, Bonnevalle A, Schramm C, Olaso R, Sandron F, Boland A, Deleuze JF, Andriuta D, Anthony P, Auriacombe S, Balageas AC, Ballan G, Barbay M, Béjot Y, Belliard S, Benaiteau M, Bennys K, Bombois S, Boutoleau-Bretonnière C, Branger P, Carlier J, Cartz-Piver L, Cassagnaud P, Ceccaldi MP, Chauviré V, Chen Y, Cogez J, Cognat E, Contegal-Callier F, Corneille L, Couratier P, Cretin B, Crinquette C, Dauriat B, Dautricourt S, de la Sayette V, de Liège A, Deffond D, Demurger F, Deramecourt V, Derollez C, Dionet E, Doco Fenzy M, Dumurgier J, Dutray A, Etcharry-Bouyx F, Formaglio M, Gabelle A, Gainche-Salmon A, Godefroy O, Graber M, Gregoire C, Grimaldi S, Gueniat J, Gueriot C, Guillet-Pichon V, Haffen S, Hanta CR, Hardy C, Hautecloque G, Heitz C, Hourregue C, Jonveaux T, Jurici S, Koric L, Krolak-Salmon P, Lagarde J, Lanoiselée HM, Laurens B, Le Ber I, Le Guyader G, Leblanc A, Lebouvier T, Levy R, Lippi A, Mackowiak MA, Magnin E, Marelli C, Martinaud O, Maureille A, Migliaccio R, Milongo-Rigal E, Mohr S, Mollion H, Morin A, Nivelle J, Noiray C, Olivieri P, Paquet C, Pariente J, Pasquier F, Perron A, Philippi N, Planche V, Pouclet-Courtemanche H, Rafiq M, Rollin-Sillaire A, Roué-Jagot C, Saracino D, Sarazin M, Sauvée M, Sellal F, Teichmann M, Thauvin C, Thomas Q, Tisserand C, Turpinat C, Van Damme L, Vercruysse O, Villain N, Wagemann N, Charbonnier C, Wallon D.
Genet Med. 2024 May;26(5):101082. doi: 10.1016/j.gim.2024.101082.
> 35- Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screening.
Nicolas G, Zaréa A, Lacour M, Quenez O, Rousseau S, Richard AC, Bonnevalle A, Schramm C, Olaso R, Sandron F, Boland A, Deleuze JF, Andriuta D, Anthony P, Auriacombe S, Balageas AC, Ballan G, Barbay M, Béjot Y, Belliard S, Benaiteau M, Bennys K, Bombois S, Boutoleau-Bretonnière C, Branger P, Carlier J, Cartz-Piver L, Cassagnaud P, Ceccaldi MP, Chauviré V, Chen Y, Cogez J, Cognat E, Contegal-Callier F, Corneille L, Couratier P, Cretin B, Crinquette C, Dauriat B, Dautricourt S, de la Sayette V, de Liège A, Deffond D, Demurger F, Deramecourt V, Derollez C, Dionet E, Doco Fenzy M, Dumurgier J, Dutray A, Etcharry-Bouyx F, Formaglio M, Gabelle A, Gainche-Salmon A, Godefroy O, Graber M, Gregoire C, Grimaldi S, Gueniat J, Gueriot C, Guillet-Pichon V, Haffen S, Hanta CR, Hardy C, Hautecloque G, Heitz C, Hourregue C, Jonveaux T, Jurici S, Koric L, Krolak-Salmon P, Lagarde J, Lanoiselée HM, Laurens B, Le Ber I, Le Guyader G, Leblanc A, Lebouvier T, Levy R, Lippi A, Mackowiak MA, Magnin E, Marelli C, Martinaud O, Maureille A, Migliaccio R, Milongo-Rigal E, Mohr S, Mollion H, Morin A, Nivelle J, Noiray C, Olivieri P, Paquet C, Pariente J, Pasquier F, Perron A, Philippi N, Planche V, Pouclet-Courtemanche H, Rafiq M, Rollin-Sillaire A, Roué-Jagot C, Saracino D, Sarazin M, Sauvée M, Sellal F, Teichmann M, Thauvin C, Thomas Q, Tisserand C, Turpinat C, Van Damme L, Vercruysse O, Villain N, Wagemann N, Charbonnier C, Wallon D.
Genet Med. 2024 May;26(5):101082. doi: 10.1016/j.gim.2024.101082.
> 33- Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial.
Wagemann O, Liu H, Wang G, Shi X, Bittner T, Scelsi MA, Farlow MR, Clifford DB, Supnet-Bell C, Santacruz AM, Aschenbrenner AJ, Hassenstab JJ, Benzinger TLS, Gordon BA, Coalier KA, Cruchaga C, Ibanez L, Perrin RJ, Xiong C, Li Y, Morris JC, Lah JJ, Berman SB, Roberson ED, van Dyck CH, Galasko D, Gauthier S, Hsiung GR, Brooks WS, Pariente J, Mummery CJ, Day GS, Ringman JM, Mendez PC, St George-Hyslop P, Fox NC, Suzuki K, Okhravi HR, Chhatwal J, Levin J, Jucker M, Sims JR, Holdridge KC, Proctor NK, Yaari R, Andersen SW, Mancini M, Llibre-Guerra J, Bateman RJ, McDade E; Dominantly Inherited Alzheimer Network–Trials Unit.
JAMA Neurol. 2024 Apr 29:e240991. doi: 10.1001/jamaneurol.2024.0991.
> 26- Robust thalamic nuclei segmentation from T1-weighted MRI using polynomial intensity transformation.
Vidal JP, Danet L, Péran P, Pariente J, Bach Cuadra M, Zahr NM, Barbeau EJ, Saranathan M.
Brain Struct Funct. 2024 Mar 28. doi: 10.1007/s00429-024-02777-5.
> 24- MRI hypoperfusion as a determinant of cognitive impairment in adults with Moyamoya angiopathy.
Giroud M, Planton M, Darcourt J, Raposo N, Brandicourt P, Mirabel H, Hervé D, Viguier A, Albucher JF, Pariente J, Olivot JM, Bonneville F, Péran P, Calviere L.
Eur Stroke J. 2024 Mar 19:23969873241240829. doi: 10.1177/23969873241240829.
> 81- The long-term impact of irradiation on functional connectivity in brain circuits involved in memory processes after pediatric posterior fossa tumor.
Baudou E, Peran P, Tensaouti F, Arribarat G, Pariente J, Courbieres N, Pollidoro L, Bertozzi AI, Gambart M, Sevely A, Roques M, Ducassou A, Danna J, Tallet J, Dufour C, Chaix Y, Laprie A.
Radiother Oncol. 2023 Dec 23:110073. doi: 10.1016/j.radonc.2023.110073.
> 69- Effects of sociodemographic and player characteristics on baseline cognitive performance in 1000 rugby players: A retrospective 8-year follow-up study.
Julien A, Tessier S, Tisserand C, Péran P, Planton M, Pariente J, Brauge D.
J Sci Med Sport. 2023 Sep 21:S1440-2440(23)00414-0. doi: 10.1016/j.jsams.2023.09.013.
> 60- Expressive Prosody in Patients With Focal Anterior Temporal Neurodegeneration.
Geraudie A, Pressman PS, Pariente J, Millanski C, Palser ER, Ratnasiri BM, Battistella G, Mandelli ML, Miller ZA, Miller BL, Sturm V, Rankin KP, Gorno-Tempini ML, Montembeault M.
Neurology. 2023 Aug 22;101(8):e825-e835. doi: 10.1212/WNL.0000000000207516.
> 59- Clinical heterogeneity of neuro-inflammatory PET profiles in early Alzheimer’s disease.
Gouilly D, Salabert AS, Bertrand E, Goubeaud M, Catala H, Germain J, Ainaoui N, Rafiq M, Benaiteau M, Carlier J, Nogueira L, Planton M, Hitzel A, Méligne D, Sarton B, Silva S, Lemesle B, Payoux P, Thalamas C, Péran P, Pariente J.
Front Neurol. 2023 Jul 31;14:1189278. doi: 10.3389/fneur.2023.1189278.
> 48- Physical activity, biomarkers of brain pathologies and dementia risk: Results from the Memento clinical cohort.
Grasset L, Planche V, Bouteloup V, Azouani C, Dubois B, Blanc F, Paquet C, David R, Belin C, Jonveaux T, Julian A, Pariente J, Mangin JF, Chêne G, Dufouil C; Memento Cohort Study Group.
Alzheimers Dement. 2023 Jul 8. doi: 10.1002/alz.13360.
> 36-Huntington’s Disease with Small CAG Repeat Expansions.
Heinzmann A, Sayah S, Lejeune FX, Hahn V, Teichmann M, Monin ML, Marchionni E, Gérard F, Charles P, Pariente J, Durr A.
Mov Disord. 2023 Jun 8. doi: 10.1002/mds.29427.
> 31- Phenotype and imaging features associated with APP duplications.
Grangeon L, Charbonnier C, Zarea A, Rousseau S, Rovelet-Lecrux A, Bendetowicz D, Lemaitre M, Malrain C, Quillard-Muraine M, Cassinari K, Maltete D, Pariente J, Moreaud O, Magnin E, Cretin B, Mackowiak MA, Sillaire AR, Vercelletto M, Dionet E, Felician O, Rod-Olivieri P, Thomas-Antérion C, Godeneche G, Sauvée M, Cartz-Piver L, Le Ber I, Chauvire V, Jonveaux T, Balageas AC, Laquerriere A, Duyckaerts C, Vital A, de Paula AM, Meyronet D, Guyant-Marechal L, Hannequin D, Tournier-Lasserve E, Campion D; CNR-MAJ collaborators; Nicolas G, Wallon D.
Alzheimers Res Ther. 2023 May 11;15(1):93. doi: 10.1186/s13195-023-01172-2.
> 23- Impact of a pediatric posterior fossa tumor and its treatments on motor procedural learning.
Baudou E, Danna J, Tallet J, Pollidoro L, Tensaouti F, Bertozzi AI, Pariente J, Courbieres N, Dufour C, Grill J, Chaix Y, Laprie A.
Eur J Paediatr Neurol. 2023 Apr 10;44:37-45. doi: 10.1016/j.ejpn.2023.03.005.
> 22- Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease.
Chen CD, McCullough A, Gordon B, Joseph-Mathurin N, Flores S, McKay NS, Hobbs DA, Hornbeck R, Fagan AM, Cruchaga C, Goate AM, Perrin RJ, Wang G, Li Y, Shi X, Xiong C, Pontecorvo MJ, Klein G, Su Y, Klunk WE, Jack C, Koeppe R, Snider BJ, Berman SB, Roberson ED, Brosch J, Surti G, Jiménez-Velázquez IZ, Galasko D, Honig LS, Brooks WS, Clarnette R, Wallon D, Dubois B, Pariente J, Pasquier F, Sanchez-Valle R, Shcherbinin S, Higgins I, Tunali I, Masters CL, van Dyck CH, Masellis M, Hsiung R, Gauthier S, Salloway S, Clifford DB, Mills S, Supnet-Bell C, McDade E, Bateman RJ, Benzinger TLS; DIAN-TU Study Team.
Eur J Nucl Med Mol Imaging. 2023 Apr 5. doi: 10.1007/s00259-023-06209-0.
> 12- Beyond the amyloid cascade: An update of Alzheimer’s disease pathophysiology
Gouilly D, Rafiq M, Nogueira L, Salabert AS, Payoux P, Péran P, Pariente J.
Rev Neurol (Paris). 2023 Mar 9:S0035-3787(23)00870-6. doi: 10.1016/j.neurol.2022.12.006.
> 82- Challenging diagnosis and treatment decision of a long-history autoantibody-negative autoimmune encephalitis.
Calvat P, Leung C, Bost C, Fortenfant F, Simonetta-Moreau M, Pariente J, Rafiq M, Brefel-Courbon C, Rascol O, Fabbri M, Ory-Magne F.
Parkinsonism Relat Disord. 2022 Dec 7:105232. doi: 10.1016/j.parkreldis.2022.105232.
> 67- Brain Metabolic Profile in Presymptomatic GRN Carriers Throughout a 5-Year Follow-up.
Saracino D, Sellami L, Boniface H, Houot M, Pélégrini-Issac M, Funkiewiez A, Rinaldi D, Locatelli M, Azuar C, Causse-Lemercier V, Jaillard A, Pasquier F, Chastan M, Wallon D, Hitzel A, Pariente J, Pallardy A, Boutoleau-Bretonnière C, Guedj E, Didic M, Migliaccio R, Kas A, Habert MO, Le Ber I; Predict-PGRN.
Neurology. 2022 Oct 18:10.1212/WNL.0000000000201439. doi: 10.1212/WNL.0000000000201439.
> 54- Update on the efficacy of cognitive rehabilitation following moderate to severe traumatic brain injury: a scoping review.
Julien A, Danet L, Loisel M, Brauge D, Pariente J, Péran P, Planton M.
Arch Phys Med Rehabil. 2022 Jul 31:S0003-9993(22)00533-0. doi: 10.1016/j.apmr.2022.07.007
> 30- Explaining the association between social and lifestyle factors and cognitive functions: a pathway analysis in the Memento cohort.
Grasset L, Proust-Lima C, Mangin JF, Habert MO, Dubois B, Paquet C, Hanon O, Gabelle A, Ceccaldi M, Annweiler C, David R, Jonveaux T, Belin C, Julian A, Rouch-Leroyer I, Pariente J, Locatelli M, Chupin M, Chêne G, Dufouil C; Memento Cohort Study group.
Alzheimers Res Ther. 2022 May 18;14(1):68. doi: 10.1186/s13195-022-01013-8.
> 27- Sleep: The Tip of the Iceberg in the Bidirectional Link Between Alzheimer’s Disease and Epilepsy.
B Szabo A, Cretin B, Gérard F, Curot J, J Barbeau E, Pariente J, Dahan L, Valton L.
Front Neurol. 2022 Apr 11;13:836292. doi: 10.3389/fneur.2022.836292.
> 4- Neuroinflammation PET imaging of the translocator protein (TSPO) in Alzheimer’s disease: an update.
Gouilly D, Saint-Aubert L, Ribeiro MJ, Salabert AS, Tauber C, Péran P, Arlicot N, Pariente J, Payoux P.
Eur J Neurosci. 2022 Jan 26. doi: 10.1111/ejn.15613.
> 73- Primary progressive aphasias associated with C9orf72 expansions: Another side of the story.
Saracino D, Géraudie A, Remes AM, Ferrieux S, Noguès-Lassiaille M, Bottani S, Cipriano L, Houot M, Funkiewiez A, Camuzat A, Rinaldi D, Teichmann M, Pariente J, Couratier P, Boutoleau-Bretonnière C, Auriacombe S, Etcharry-Bouyx F, Levy R, Migliaccio R, Solje E, Le Ber I; French research network on FTD/FTD-ALS and PREV-DEMALS study groups.
Cortex. 2021 Oct 1;145:145-159. doi: 10.1016/j.cortex.2021.09.005.
> 72- A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescence
Baudou E, Pariente P, Péran P, Tensaouti F, Pollidoro L, Meligne D, Ducassou A, Gros-Dagnac H, Arribarat G, Desirat JP, Bertozzi AI, Gambart M, Larrieu-Ciron D, Barbolosi D, Muracciole X, Lemesle B, Sevely A, Roques M, Laprie A
Clinical & Translational Radiation Oncology. 2021 oct. S2405-6308(21)00091-4 https://doi.org/10.1016/j.ctro.2021.10.006
> 52- Taking the A Train? Limited Consistency of Aβ42 and the Aβ42/40 Ratio in the AT(N) Classification.
Gouilly D, Tisserand C, Nogueira L, Saint-Lary L, Rousseau V, Benaiteau M, Rafiq M, Carlier J, Milongo-Rigal E, Pagès JC, Pariente J.
J Alzheimers Dis. 2021 Aug 8. doi: 10.3233/JAD-210236.
> 47- Plasma NfL levels and longitudinal change rates in C9orf72 and GRN-associated diseases: from tailored references to clinical applications.
Saracino D, Dorgham K, Camuzat A, Rinaldi D, Rametti-Lacroux A, Houot M, Clot F, Martin-Hardy P, Jornea L, Azuar C, Migliaccio R, Pasquier F, Couratier P, Auriacombe S, Sauvée M, Boutoleau-Bretonnière C, Pariente J, Didic M, Hannequin D, Wallon D; French Research Network on FTD/FTD-ALS; PREV-DEMALS and Predict-PGRN study groups, Colliot O, Dubois B, Brice A, Levy R, Forlani S, Le Ber I.
J Neurol Neurosurg Psychiatry. 2021 Aug 4:jnnp-2021-326914. doi: 10.1136/jnnp-2021-326914.
> 29- Language Network Connectivity Increases in Early Alzheimer’s Disease.
Pistono A, Senoussi M, Guerrier L, Rafiq M, Gimeno M, Péran P, Jucla M, Pariente J.
J Alzheimers Dis. 2021 May 18. doi: 10.3233/JAD-201584.
> 15- The role of neuropsychological assessment in adults with attention deficit/hyperactivity disorders.
Planton M, Lemesle B, Cousineau M, Carlier J, Milongo-Rigal E, Carle-Toulemonde G, Salles J, Pariente J.
Voir la publication
Rev Neurol (Paris). 2021 Feb 19:S0035-3787(21)00042-4. doi: 10.1016/j.neurol.2021.01.006.
> 16- Atypical clinical presentation and typical FTD atrophy: 17-year clinical follow-up and MRI analysis of a slowly progressive bvFTD associated with C9orf72 expansion.
Géraudie A, Guerrier L, Le Ber I, Clot F, Péran P, Pariente J.
<a
Voir la publication
Rev Neurol (Paris). 2020 Mar 13. pii: S0035-3787(20)30394-5. doi: 10.1016/j.neurol.2020.02.003.
> 15- Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience.
Sellami L, Rucheton B, Ben Younes I, Camuzat A, Saracino D, Rinaldi D, Epelbaum S, Azuar C, Levy R, Auriacombe S, Hannequin D, Pariente J, Barbier M, Boutoleau-Bretonnière C, Couratier P, Pasquier F, Deramecourt V, Sauvée M, Sarazin M, Lagarde J, Roué-Jagot C, Forlani S, Jornea L, David I, LeGuern E, Dubois B, Brice A, Clot F, Lamari F, Le Ber I. French Research Network on FTLD/FTLD-ALS; PREVDEMALS and Predict-PGRN Groups
Voir la publication
Neurobiol Aging. 2020 Feb 21. pii: S0197-4580(20)30047-6. doi: 10.1016/j.neurobiolaging.2020.02.014.
> 14- Risk of Intracerebral Hemorrhage and Mortality After Convexity Subarachnoid Hemorrhage in Cerebral Amyloid Angiopathy.
Calviere L, Viguier A, Patsoura S, Rousseau V, Albucher JF, Planton M, Pariente J, Cognard C, Olivot JM, Bonneville F, Raposo N.
Voir la publication
Stroke. 2019 Sep;50(9):2562-2564. doi: 10.1161/STROKEAHA.119.026244.
> 2- Amyloid-β transmission through cardiac surgery using cadaveric dura mater patch.
Raposo N, Planton M, Siegfried A, Calviere L, Payoux P, Albucher JF, Viguier A, Delisle MB, Uro-Coste E, Chollet F, Bonneville F, Olivot JM, Pariente J.
Voir la publication
J Neurol Neurosurg Psychiatry. 2020 Jan 20. pii: jnnp-2019-321927. doi: 10.1136/jnnp-2019-321927.
> 1- Florbetapir Regional Distribution in Cerebral Amyloid Angiopathy and Alzheimer’s Disease: A PET Study.
Planton M, Saint-Aubert L, Raposo N, Payoux P, Salabert AS, Albucher JF, Olivot JM, Péran P, Pariente J.
Voir la publication
J Alzheimers Dis. 2020 Jan 13. doi: 10.3233/JAD-190625.
> 59- Diagnosis Clinical Criteria Of Sport Related Concussion: Toward An Operational Criteria Definition In France.
Decq P, Brauge D, Calmat A, Cassoudesalle H, Dehail P, Deroche F, Frey A, Julia M, Van PL, Lecocq J, Mekies C, Monroche A, Pariente J, Rousseau R, Vesselle B, Einsargueix G.
Voir la publication
Neurochirurgie. 2020 Dec 2:S0028-3770(20)30475-6. doi: 10.1016/j.neuchi.2020.11.010.
> 57- Increased functional connectivity supports language performance in healthy aging despite gray matter loss.
Pistono A, Guerrier L, Péran P, Rafiq M, Giméno M, Bézy C, Pariente J, Jucla M.
Voir la publication
Neurobiol Aging. 2020 Sep 28;98:52-62. doi: 10.1016/j.neurobiolaging.2020.09.015.
> 54- Underlying Small Vessel Disease Associated With Mixed Cerebral Microbleeds.
Blanc C, Viguier A, Calviere L, Planton M, Albucher JF, Rousseau V, Sommet A, Bonneville F, Pariente J, Olivot JM, Raposo N.
Voir la publication
Front Neurol. 2019 Oct 23;10:1126. doi: 10.3389/fneur.2019.01126.
> 52- Post-stroke remodeling processes in animal models and humans
Cirillo C, Brihmat N, Castel-Lacanal E, Le Friec A, Barbieux-Guillot M, Raposo N, Pariente J, Viguier A, Simonetta-Moreau M, Albucher JF, Olivot JM, Desmoulin F, Marque P, Chollet F, Loubinoux I.
Voir la publication
J Cereb Blood Flow Metab. 2019 Oct 23:271678X19882788. doi: 10.1177/0271678X19882788.
> 51- Posterior Cortical Atrophy: Does Complaint Match the Impairment? A Neuropsychological and FDG-PET Study
Guerrier L, Cransac C, Pages B, Saint-Aubert L, Payoux P, Péran P, Pariente J
Voir la publication
Front Neurol. 2019 Sep 20;10:1010. doi: 10.3389/fneur.2019.01010.
> 46- Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia.
Bergeron D, Gorno-Tempini ML, Rabinovici GD, Santos-Santos MA, Seeley W, Miller BL, Pijnenburg Y, Keulen MA, Groot C, van Berckel BNM, van der Flier WM, Scheltens P, Rohrer JD, Warren JD, Schott JM, Fox NC, Sanchez-Valle R, Grau-Rivera O, Gelpi E, Seelaar H, Papma JM, van Swieten JC, Hodges JR, Leyton CE, Piguet O, Rogalski EJ, Mesulam MM, Koric L, Nora K, Pariente J, Dickerson B, Mackenzie IR, Hsiung GR, Belliard S, Irwin DJ, Wolk DA, Grossman M, Jones M, Harris J, Mann D, Snowden JS, Chrem-Mendez P, Calandri IL, Amengual AA, Miguet-Alfonsi C, Magnin E, Magnani G, Santangelo R, Deramecourt V, Pasquier F, Mattsson N, Nilsson C, Hansson O, Keith J, Masellis M, Black SE, Matías-Guiu JA, Cabrera-Martin MN, Paquet C, Dumurgier J, Teichmann M, Sarazin M, Bottlaender M, Dubois B, Rowe CC, Villemagne VL, Vandenberghe R, Granadillo E, Teng E, Mendez M, Meyer PT, Frings L, Lleó A, Blesa R, Fortea J, Seo SW, Diehl-Schmid J, Grimmer T, Frederiksen KS, Sánchez-Juan P, Chételat G, Jansen W, Bouchard RW, Laforce RJ, Visser PJ, Ossenkoppele R
Voir la publication
Ann Neurol. 2018 Nov;84(5):729-740. doi: 10.1002/ana.25333.
> 44- Grey Matter changes in treatment-resistant depression during electroconvulsive therapy.
Yrondi A, Nemmi F, Billoux S, Giron A, Sporer M, Taib S, Salles J, Pierre D, Thalamas C, Rigal E, Danet L, Pariente J, Schmitt L, Arbus C, Péran P.
Voir la publication
J Affect Disord. 2019 Jul 31;258:42-49. doi: 10.1016/j.jad.2019.07.075.
> 42- Enlarged perivascular spaces and florbetapir uptake in patients with intracerebral hemorrhage.
Raposo N, Planton M, Payoux P, Péran P, Albucher JF, Calviere L, Viguier A, Rousseau V, Hitzel A, Chollet F, Olivot JM, Bonneville F, Pariente J.
Voir la publication
Eur J Nucl Med Mol Imaging. 2019 Jul 29. doi: 10.1007/s00259-019-04441-1.
> 62- Acute ischemic lesions in cerebral amyloid angiopathy-related inflammation.
Sallèles E, Bonneville F, Delisle MB, Rigal E, Raposo N, Pariente J.
<a
Voir la publication
Rev Neurol (Paris). 2019 Oct;175(9):575-577. doi: 10.1016/j.neurol.2019.01.399. Epub 2019 May 29.
> 18- Biallelic MYORG mutation carriers exhibit primary brain calcification with a distinct phenotype.
Grangeon L, Wallon D, Charbonnier C, Quenez O, Richard AC, Rousseau S, Budowski C, Lebouvier T, Corbille AG, Vidailhet M, Méneret A, Roze E, Anheim M, Tranchant C, Favrole P, Antoine JC, Defebvre L, Ayrignac X, Labauge P, Pariente J, Clanet M, Maltête D, Rovelet-Lecrux A, Boland A, Deleuze JF, Frebourg T, Hannequin D, Campion D, Nicolas G; French PFBC study group .
Brain. 2019 Apr 22. pii: awz095. doi: 10.1093/brain/awz095.
> 5- An Analysis of Famous Person Semantic Memory in Aging.
Pistono A, Busigny T, Jucla M, Cabirol A, Dinnat AL, Pariente J, Barbeau EJ.
Exp Aging Res. 2019 Jan 31:1-20. doi: 10.1080/0361073X.2018.1560118.
> 57- What happens when nothing happens? An investigation of pauses as a compensatory mechanism in early Alzheimer’s disease.
Pistono A, Pariente J, Bézy C, Lemesle B, Le Men J, Jucla M.
Neuropsychologia. 2018 Dec 26. pii: S0028-3932(18)30376-2. doi: 10.1016
> 54- Discourse macrolinguistic impairment as a marker of linguistic and extralinguistic functions decline in early Alzheimer’s disease.
Pistono A, Jucla M, Bézy C, Lemesle B, Le Men J, Pariente J.
Int J Lang Commun Disord. 2018 Nov 15. doi: 10.1111/1460-6984.12444.
> 59- Serotonin Selective Reuptake Inhibitors (SSRIs) and Stroke.
Chollet F, Rigal J, Marque P, Barbieux-Guillot M, Raposo N, Fabry, Albucher JF, Pariente J, Loubinoux I.
Curr Neurol Neurosci Rep. 2018 Oct 23;18(12):100. doi: 10.1007/s11910-018-0904-9.
> 44- Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia.
Bergeron D, Gorno-Tempini ML, Rabinovici GD, Santos-Santos MA, Seeley W, Miller BL, Pijnenburg Y, Keulen MA, Groot C, van Berckel BNM, van der Flier WM, Scheltens P, Rohrer JD, Warren JD, Schott JM, Fox NC, Sanchez-Valle R, Grau-Rivera O, Gelpi E, Seelaar H, Papma JM, van Swieten JC, Hodges JR, Leyton CE, Piguet O, Rogalsky EJ, Mesulam MM, Koric L, Nora K, Pariente J, Dickerson B, Mackenzie IR, Hsiung GR, Belliard S, Irwin DJ, Wolk DA, Grossman M, Jones M, Harris J, Mann D, Snowden JS, Chrem-Mendez P, Calandri IL, Amengual AA, Miguet-Alfonsi C, Magnin E, Magnani G, Santangelo R, Deramecourt V, Pasquier F, Mattsson N, Nilsson C, Hansson O, Keith J, Masellis M, Black SE, Matías-Guiu JA, Cabrera-Martin MN, Paquet C, Dumuirger J, Teichmann M, Sarazin M, Bottlaender M, Dubois B, Rowe CC, Villemagne VL, Vandenberghe R, Granadillo E, Teng E, Mendez M, Meyer PT, Frings L, Lleó A, Blesa R, Fortea J, Seo SW, Diehl-Schmid J, Grimmer T, Frederiksen KS, Sánchez-Juan P, Chételat G, Jansen W, Bouchard RW, Robert L Jr, Visser PJ, Ossenkoppele R.
Ann Neurol. 2018 Sep 26. doi: 10.1002/ana.25333.
> 47- Structural, Microstructural, and Metabolic Alterations in Primary Progressive Aphasia Variants.
Routier A, Habert MO, Bertrand A, Kas A, Sundqvist M, Mertz J, David PM, Bertin H, Belliard S, Pasquier F, Bennys K, Martinaud O, Etcharry-Bouyx F, Moreaud O, Godefroy O, Pariente J, Puel M, Couratier P, Boutoleau-Bretonnière C, Laurent B, Migliaccio R, Dubois B, Colliot O, Teichmann M.
Front Neurol. 2018 Sep 18;9:766. doi: 10.3389/fneur.2018.00766. eCollection 2018.
> 49- The Regulatory Role of the Human Mediodorsal Thalamus.
Pergola G, Danet L, Pitel AL, Carlesimo GA, Segobin S, Pariente J, Suchan B, Mitchell AS, Barbeau EJ.
Trends Cogn Sci. 2018 Sep 17. pii: S1364-6613(18)30205-5. doi: 10.1016/j.tics.2018.08.006.
> 24- Impact of spontaneous intracerebral hemorrhage on cognitive functioning: An update.
Planton M, Raposo N, Danet L, Albucher JF, Péran P, Pariente J.
Rev Neurol (Paris). 2017 Jul - Aug;173(7-8):481-489. doi: 10.1016/j.neurol.2017.06.010. Epub 2017 Aug 31. Review.
> 37- Involvement of the Cingulate Cortex in Anosognosia: A Multimodal Neuroimaging Study in Alzheimer’s Disease Patients.
Guerrier L, Men JL, Gane A, Planton M, Salabert AS, Payoux P, Dumas H, Bonneville F, Péran P, Pariente J.
J Alzheimers Dis. 2018 Jul 20. doi: 10.3233/JAD-180324.
> 33- Superior explicit memory despite severe developmental amnesia: In-depth case study and neural correlates.
Jonin PY, Besson G, Lajoie R, Pariente J, Belliard S, Barillot C, Barbeau EJ.
Hippocampus. 2018 Jul 11. doi: 10.1002/hipo.23010.
> 9- Cortical superficial siderosis and acute convexity subarachnoid hemorrhage in cerebral amyloid angiopathy.
Raposo N, Calviere L, Cazzola V, Planton M, Patsoura S, Wargny M, Albucher JF, Sommet A, Olivot JM, Chollet F, Pariente J, Bonneville F, Viguier A.
Eur J Neurol. 2018 Feb;25(2):253-259. doi: 10.1111/ene.13484. Epub 2017 Nov 23.
> 4- Cerebral microbleeds and CSF Alzheimer biomarkers in primary progressive aphasias.
Mendes A, Bertrand A, Lamari F, Colliot O, Routier A, Godefroy O, Etcharry-Bouyx F, Moreaud O, Pasquier F, Couratier P, Bennys K, Vercelletto M, Martinaud O, Laurent B, Pariente J, Puel M, Epelbaum S, Belliard S, Kaaouana T, Fillon L, Chupin M, Dubois B, Teichmann M; PHRC “CAPP” Study Group.
Neurology. 2018 Feb 14. pii: 10.1212/doi: 10.1212
> 28- Cognitive complaint in early Parkinson’s disease: A pilot study.
Dupouy J, Ory-Magne F, Mekies C, Rousseau V, Puel M, Rerat K, Pariente J, Brefel-Courbon C; PARKMIP group.
Acta Neurol Scand. 2018 Jan;137(1):59-66. doi: 10.1111/ane.12808. Epub 2017 Aug 22.
> 73- Patient emergency assessment following deliberate self-poisoning with benzodiazepines: Can cognitive markers predict recall of the psychiatric interview? A pilot study.
Salles J, Pariente J, Dimeglio C, Gandia P, Lemesle B, Giron A, Franchitto N, Schmitt L, Very E
J Psychopahrmacology 2017 Oct;31 (10); 1362-1368 doi: 10.1177/0269881117705088
> 54- Cortical superficial siderosis and acute convexity subarachnoid hemorrhage in cerebral amyloid angiopathy.
Raposo N, Calviere L, Cazzola V, Planton M, Patsoura S, Wargny M, Albucher JF, Sommet A, Olivot JM, Chollet F, Pariente J, Bonneville F, Viguier A.
Eur J Neurol. 2017 Oct 20. doi: 10.1111/ene.13484.
> 39- Alteration of rhythmic unimanual tapping and anti-phase bimanual coordination in Alzheimer’s disease: A sign of inter-hemispheric disconnection?
Martin E, Blais M, Albaret JM, Pariente J, Tallet J.
Hum Mov Sci. 2017 Oct;55:43-53. doi: 10.1016/j.humov.2017.07.007.
> 51- Cerebral amyloid angiopathy-related cognitive impairment: The search for a specific neuropsychological pattern.
Planton M, Raposo N, Albucher JF, Pariente J.
Rev Neurol (Paris). 2017 Oct 6. pii: S0035-3787(17)30733-6. doi: 10.1016/j.neurol.2017.09.006.
> 47- Depression and sports-related concussion: A systematic review.
Yrondi A, Brauge D, LeMen J, Arbus C, Pariente J.
Presse Med. 2017 Sep 14. pii: S0755-4982(17)30372-X. doi: 10.1016/j.lpm.2017.08.013.
> 40- Familiarity and recollection vs representational models of medial temporal lobe structures: a single-case study.
Lacot E, Vautier S, Kőhler S, Pariente J, Martin C, Puel M, Lotterie JA, Barbeau EJ.
Neuropsychologia. 2017Sep;104:76-91. doi: 10.1016/j.neuropsychologia.2017.07.032.
> 41- Cognitive complaint in early Parkinson’s disease: A pilot study.
Dupouy J, Ory-Magne F, Mekies C, Rousseau V, Puel M, Rerat K, Pariente J, Brefel-Courbon C; PARKMIP group.
Acta Neurol Scand. 2017 Aug 22. doi: 10.1111/ane.12808.
> 43- Impact of spontaneous intracerebral hemorrhage on cognitive functioning: An update.
Planton M, Raposo N, Danet L, Albucher JF, Péran P, Pariente J. Rev Neurol (Paris).
2017 Aug 21. pii: S0035-3787(17)30543-X. doi: 10.1016/j.neurol.2017.06.010.
> 38- Florbetapir imaging in cerebral amyloid angiopathy-related hemorrhages.
Raposo N, Planton M, Péran P, Payoux P, Bonneville F, Lyoubi A, Albucher JF, Acket B, Salabert AS, Olivot JM, Hitzel A, Chollet F, Pariente J.
Neurology. 2017 Jul 19. pii: 10.1212/WNL.0000000000004228. doi: 10.1212/WNL.0000000000004228.
> 27- High prevalence of cognitive impairment after intracerebral hemorrhage.
Planton M, Saint-Aubert L, Raposo N, Branchu L, Lyoubi A, Bonneville F, Albucher JF, Olivot JM, Péran P, Pariente J.
PLoS One. 2017 Jun 1;12(6):e0178886. doi: 10.1371/journal.pone.0178886. eCollection 2017.
> 19- Inter-individual variability in discourse informativeness in elderly populations.
Pistono A, Pariente J, Bézy C, Pastor J, Tran TM, Renard A, Fossard M, Nespoulous JL, Jucla M.
Clin Linguist Phon. 2017;31(5):391-408. doi: 10.1080/02699206.2016.1277390.
> 70- Inter-individual variability in discourse informativeness in elderly populations.
Pistono A, Pariente J , Bézy C, Pastor J, Tran TM, Renard A, Fossard M, Nespoulous JL, Jucla M.
Clin Linguist Phon. 2017;31(5):391-408. doi: 10.1080/02699206.2016.1277390. Epub 2017 Feb 7.
> 9- Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI).
Nathan PJ, Lim YY, Abbott R, Galluzzi S, Marizzoni M, Babiloni C, Albani D, Bartres-Faz D, Didic M, Farotti L, Parnetti L, Salvadori N, Müller BW, Forloni G, Girtler N, Hensch T, Jovicich J, Leeuwis A, Marra C, Molinuevo JL, Nobili F, Pariente J, Payoux P, Ranjeva JP, Rolandi E, Rossini PM, Schönknecht P, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium.
Neurobiol Aging. 2017 Jan 18;53:1-10. doi: 10.1016/j.neurobiolaging.2017.01.013.
> 71- N270 sensitivity to conflict strength and working memory: A combined ERP and sLORETA study.
Scannella S, Pariente J, De Boissezon X, Castel-Lacanal E, Chauveau N, Causse M, Dehais F, Pastor J.
Behav Brain Res. 2016 Jan 15;297:231-40. doi: 10.1016/j.bbr.2015.10.014. Epub 2015 Oct 23.
> 39- Multimodal Magnetic Resonance Imaging in Alzheimer’s Disease Patients at Prodromal Stage.
Eustache P, Nemmi F, Saint-Aubert L, Pariente J, Péran P.
J Alzheimers Dis. 2016;50(4):1035-50. doi: 10.3233/JAD-150353.
> 27- Seizures in dominantly inherited Alzheimer disease.
Zarea A, Charbonnier C, Rovelet-Lecrux A, Nicolas G, Rousseau S, Borden A, Pariente J, Le Ber I, Pasquier F, Formaglio M, Martinaud O, Rollin-Sillaire A, Sarazin M, Croisile B, Boutoleau-Bretonnière C, Ceccaldi M, Gabelle A, Chamard L, Blanc F, Sellal F, Paquet C, Campion D, Hannequin D, Wallon D; PHRC GMAJ Collaborators..
Neurology. 2016 Aug 30;87(9):912-9. doi: 10.1212/WNL.0000000000003048.
> 36- Pauses During Autobiographical Discourse Reflect Episodic Memory Processes in Early Alzheimer’s Disease.
Pistono A, Jucla M, Barbeau EJ, Saint-Aubert L, Lemesle B, Calvet B, Köpke B, Puel M, Pariente J.
J Alzheimers Dis. 2016;50(3):687-98. doi: 10.3233/JAD-150408.
> 51- Case report of Lewy body disease mimicking Creutzfeldt-Jakob disease in a 44-year-old man.
Saint-Aubert L, Pariente J, Dumas H, Payoux P, Brandel JP, Puel M, Vital A, Guedj E, Lesage S, Peoc’h K, Brefel Courbon C, Ory Magne F.
BMC Neurol. 2016 Jul 30;16:122. doi: 10.1186/s12883-016-0643-y.
> 43- Clinical and biomarker profiling of prodromal Alzheimer’s disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a ‘European ADNI study’.
Galluzzi S, Marizzoni M, Babiloni C, Albani D, Antelmi L, Bagnoli C, Bartres-Faz D, Cordone S, Didic M, Farotti L, Fiedler U, Forloni G, Girtler N, Hensch T, Jovicich J, Leeuwis A, Marra C, Molinuevo JL, Nobili F, Pariente J, Parnetti L, Payoux P, Del Percio C, Ranjeva JP, Rolandi E, Rossini PM, Schönknecht P, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium..
J Intern Med. 2016 Jun;279(6):576-91. doi: 10.1111/joim.12482.
> 45- Atropinic (Anticholinergic) Burden in Parkinson’s Disease.
De Germay S, Montastruc JL, Rousseau V, Chebane L, Bondon-Guitton E, Moulis F, Durrieu G, Bagheri H, Rascol O, Pariente A, Bégaud B, Montastruc F.
Mov Disord. 2016 May;31(5):632-6. doi: 10.1002/mds.26595.
> Thalamic amnesia after infarct: The role of the mammillothalamic tract and mediodorsal nucleus.
Danet L, Barbeau EJ, Eustache P, Planton M, Raposo N, Sibon I, Albucher JF, Bonneville F, Peran P, Pariente J.
Neurology. 2015 Dec 15;85(24):2107-15. doi: 10.1212/WNL.0000000000002226.
> White matter disruption at the prodromal stage of Alzheimer’s disease: relationships with hippocampal atrophy and episodic memory performance.
Rémy F, Vayssière N, Saint-Aubert L, Barbeau E, Pariente J.
Neuroimage Clin. 2015 Jan 27;7:482-92. doi: 10.1016/j.nicl.2015.01.014.
> A systematic study of topographical memory and posterior cerebral artery infarctions.
Busigny T, Pagès B, Barbeau EJ, Bled C, Montaut E, Raposo N, Albucher JF, Chollet F, Pariente J.
Neurology. 2014 Sep 9;83(11):996-1003. doi: 10.1212/WNL.0000000000000780.
> A case of logopenic primary progressive aphasia with C9ORF72 expansion and cortical florbetapir binding.
Saint-Aubert L, Sagot C, Wallon D, Hannequin D, Payoux P, Nemmi F, Bezy C, Chauveau N, Campion D, Puel M, Chollet F, Pariente J.
J Alzheimers Dis. 2014;42(2):413-20. doi: 10.3233/JAD-140222.
> Insight on AV-45 binding in white and grey matter from histogram analysis: a study on early Alzheimer’s disease patients and healthy subjects.
Nemmi F, Saint-Aubert L, Adel D, Salabert AS, Pariente J, Barbeau EJ, Payoux P, Péran P.
Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1408-18. doi: 10.1007/s00259-014-2728-4.
> Comparison between PET template-based method and MRI-based method for cortical quantification of florbetapir (AV-45) uptake in vivo.
Saint-Aubert L, Nemmi F, Péran P, Barbeau EJ, Payoux P, Chollet F, Pariente J.
Eur J Nucl Med Mol Imaging. 2014 May;41(5):836-43. doi: 10.1007/s00259-013-2656-8.
> 1H NMR Analysis of Cerebrospinal Fluid from Alzheimer’s Disease Patients: An Example of a Possible Misinterpretation Due to Non-Adjustment of pH.
Cruz T, Balayssac S, Gilard V, Martino R, Vincent C, Pariente J, Malet-Martino M.
Metabolites. 2014 Feb 19;4(1):115-28. doi: 10.3390/metabo4010115.